RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (10)
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.
Clayton, Obie
Elimination Disorders
Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top